NINDS Neuroscience Funding Announcements

Grants for Alzheimer's Disease Drug Discovery (R21)

Funding Contact(s): Diane DiEuliis, Ph.D.
Funding Categories: Neurodegeneration

Brief Description:
Inviting qualified researchers to submit research grant applications directed toward the discovery, development, and preclinical testing in cellular, tissue, and animal models of novel compounds for the prevention and treatment of the cognitive impairment and behavioral symptoms associated with Alzheimer's disease (AD). Applications submitted to the NIH will be assigned and reviewed according to the usual NIH peer review procedures. Meritorious applications will be funded by the assigned NIH Institutes or co-funded by the assigned NIH Institute and the Institute for the Study of Aging (ISOA). NIA has set-aside $3.0 Million total costs in FY 2006 for applications sent in response to this PA.

Grant Mechanism: R21
NIH Guide: PAS-06-261
Release Date: 2006-03-24
Expiration Date: 2009-05-02